General Surgery B-Pancreas Institute, G.B. Rossi Hospital, Department of Surgery, University of Verona Hospital Trust, Piazzale L.A. Scuro 10, Verona, Italy.
Langenbecks Arch Surg. 2013 Feb;398(2):287-94. doi: 10.1007/s00423-012-0978-9. Epub 2012 Jul 17.
The aims of this paper were to evaluate the clinical features of patients with primary duodenal adenocarcinoma and to address the prognostic relevance of different surgical and pathological variables after potentially curative pancreaticoduodenectomy.
Patients with primary duodenal adenocarcinoma observed from 2000 through 2009 were identified from a single-institution electronic database. Univariate and multivariate analyses were performed to identify factors associated with survival.
The study population consisted of 37 patients. Of these, 25 underwent pancreaticoduodenectomy, while the remaining 12 were not amenable to resection and underwent bypass operations or were given best supportive care. Overall survival after radical resection (R0) was significantly longer than after palliative surgery (180 versus 35 months, p = 0.013). On multivariate analysis, tumor grade (hazard ratio (HR) = 1.345, 95% CI = 1.28-1.91, p = 0.03) and the occurrence of postoperative or abdominal complications (HR = 1.781, 95% CI = 1.10-2.89, p = 0.037; HR = 1.878, 95% CI = 1.21-3.08, p = 0.029) were found to be significant prognostic factors for survival in patients undergoing potentially curative resection. In particular, median survival was 180 months in patients with an uneventful postoperative course and 52 months in those with abdominal complications. The 5-year overall survival rates were 100 and 60 %, respectively.
According to the present findings, the development of postoperative complications may be an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. This emphasizes the need for centralization to high-volume centers where an appropriate postoperative care can be delivered.
本文旨在评估原发性十二指肠腺癌患者的临床特征,并探讨潜在可治愈的胰十二指肠切除术后不同手术和病理变量的预后相关性。
从单机构电子数据库中确定了 2000 年至 2009 年间观察到的原发性十二指肠腺癌患者。进行单因素和多因素分析以确定与生存相关的因素。
研究人群由 37 例患者组成。其中 25 例行胰十二指肠切除术,其余 12 例不适宜切除而行旁路手术或给予最佳支持治疗。根治性切除术后(R0)的总生存率明显长于姑息性手术后(180 与 35 个月,p=0.013)。多因素分析显示,肿瘤分级(危险比(HR)=1.345,95%CI=1.28-1.91,p=0.03)和术后或腹部并发症的发生(HR=1.781,95%CI=1.10-2.89,p=0.037;HR=1.878,95%CI=1.21-3.08,p=0.029)是可切除患者生存的显著预后因素。特别是,无术后并发症患者的中位生存期为 180 个月,而有腹部并发症患者的中位生存期为 52 个月。5 年总生存率分别为 100%和 60%。
根据目前的发现,对于原发性十二指肠腺癌潜在可治愈的胰十二指肠切除术后,术后并发症的发生可能是另一个预后因素。这强调了需要集中到能够提供适当术后护理的高容量中心。